Touchstone Innovations

Touchstone Innovations create, build and invest in pioneering technology companies and licensing opportunities developed from outstanding scientific research focusing on the ‘Golden Triangle’ of London, Cambridge and Oxford.

Their robust strategy and fully integrated business model, proven over many years, begins with original idea and extends through intellectual property (IP) protection, company formation, seed funding, incubation, scale-up and supportive investment.

This provides us with a unique insight into leveraging early-stage research and turning it into substantial, high-quality, well-managed and well-funded commercial businesses.

They help scientists and entrepreneurs to commercialise their idea by protecting and licensing intellectual property, leading the formation of new companies, recruiting high-calibre management teams and providing and supporting investment.

They provide continuity of funding from start-up to scale-up, with initial investments from seed stage onwards. They remain an active investor throughout the lifetime of their portfolio companies, with the majority of their investment each year going into businesses they have lived with and understood for some time. This strategy substantially de-risks investment scale-up in their portfolio companies.

Touchstone Innovations is at the forefront of UK early-stage technology investment. Alongside their co-investors they have leveraged over £1.5 billion to help drive high technology innovation in the UK.

Touchstone Innovations, established in 2001 and headquartered in Europe., specializes in Early Stage Venture, Late Stage Venture, Seed investments across Biotechnology, Health Care, Medical, Therapeutics, Financial Services, Venture Capital, Finance, Intellectual Property, Semiconductor, Life Science. The organization boasts a portfolio of 20 investments, with an average round size of $15.2M and 6 successful exits. Their recent investments include Storm Therapeutics, Cambridge Innovation Capital, Imperial Innovations, M Ventures, Pfizer Venture Investments. The highest investment round they participated in was $18.1B. Among their most notable exits are Storm Therapeutics and Cambridge Innovation Capital. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.